AI assistant
Microbot Medical Inc. — Director's Dealing 2017
Oct 25, 2017
33819_dirs_2017-10-25_87898bb7-f4fd-4c71-80a9-637d3234033b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2017-10-17
Reporting Person: Bornstein Yoseph (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-17 | Common Stock | S | 25000 | $1.1687 | Disposed | 4930399 | Indirect |
| 2017-10-17 | Common Stock | S | 25000 | $1.1567 | Disposed | 4930399 | Indirect |
Footnotes
F1: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 50,000 shares of Issuer common stock on October 17, 2017. Accordingly, Reporting Person beneficially owned 4,930,399 shares of Issuer common stock following the reported transactions.
F2: Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. ("LSA") and of Shizim Ltd. ("Shizim"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities.